Philip Morris
Detection of Human Papillomavirus Infections in the Male Sexual Partners of Women Attending An Std Clinic in Bologna
Fields
- Author
- Chang, F.
- Costa, S.
- Guida, G.
- Hippelainen, M.
- Syrjanen, K.
- Syrjanen, S.
- Tervahauta, A.
- Vendra, C.
- Costa, S.
- Document File
- 2063654385/2063655008/Missing
- 2063654487/2063654704/Syrjanen
- Area
- CARCHMAN,RICHARD/SEC'Y FILES
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Litigation
- Iwoh/Produced
- Named Organization
- Ftr, Fabriques De Tabac Reunies S.A.
- Medical Research Council
- Pasteur Inst
- Progetto De Ricerca Oncologia
- Academy of Finland
- Bat, British American Tobacco
- Cnr
- Dkfz
- Finnish Cancer Society
- Medical Research Council
- Site
- R530
- Named Person
- Emiliaromana, R.
- Hoffren, K.
- Kemilainen, H.
- Lipponen, P.
- Orth, G.
- Sedergrenvaris, E.
- Zurhausen, H.
- Hoffren, K.
- Author (Organization)
- Intl Journal of Std + Aids
- Kuopio Cancer Research Centre
- Royal Society of Medicine Services
- Univ of Bologna
- Univ of Kuopio
- Kuopio Cancer Research Centre
- Date Loaded
- 23 May 1999
- UCSF Legacy ID
- ftf67e00
Document Images
ISSN 0956-4624
Volume 3
1992
international.
TD AID
f l1L S
jjournal -~oS
For all clinicians with an interest in
HIV, AIDS and the more "traditionaP'
sexually transmissible diseases (STD)
In-depth editorial reviews provide a
regular update
Special emphasis placed on papers
dealing with the clinical aspects of
HIV, AIDS and STD
AIDS Literature Index in each issue
provides an up-to-date source listing
of papers on AIDS and HIV published
worldwide
ished by Royal Society of Medicine Services Limited

Internatio fal TD & AID S
o
Journal S
EDITOR
W W Dinsmore (U)
ASSOCIATE EDITORS
J R W Harris (UKJ E Panconesi (/ta/y)
A Lassus (Fin/and~ M A Waugh (LIA2
EDITORIAL BOARD
D I Abrams (USA)
S Adam (UKJ
K Behbehani (/(uwait~
J S Bingham (I)
A G Bird (LIA2
S Bygdeman (SwedenJ
B Donovan (Austra/ia)
D Freedman (Eire)
B Gazzard (U)
S K Hira (Zambia~
K King Holmes
(Switzer/and~
D J Jeffries (U)
J Jordan (LIA2
F N Judson (USA)
G Kinghorn (LIA2
H C Korting (Geirnanj1)
A Lewis (NewZea/andJ
Low Bin Tick (Ma/aysia~
A Luger (Austricq)
D McCance (USA)
A McMillan (LIA2
J K Maniar (/ndia)
J Mann (ZSA)
RDMaw (U)
A Meheus (Switzer/and~
F Mulcahy (Eire)
A P Oranje (Nether/ands)
J D Oriel (II)
M E M Paalman
(1vethe1/a17ds)
C C Patterson (I)
D Petzoldt (Getmanv)
C R Philpot (Austra/ia)
A J Pinching (I/A)
T C Quinn (USA)
G L Ridgway (Z)
B Romanowski (CanadaJ
A Stary (Austria)
E Stolz (Nether/ands)
J Stratigos (Greece)
D Taylor Robinson (U)
R N Thin (U)
T Thiru Moorthy
(Singapore)
J N Weber (U)
F Zacarias (USA)
SUBSCRIPTION INFORMATION
The International Journal of STD & AIDS is published
bi-monthly by Royal Society of Medicine Services Limited,
London, UK. Annual subscription rates for Volume 3, 1992
(six issues), including postage, are as follows:
/nstitution. £90.00/US$162.00. /ndividua/. £65.00/US$120.00.
Subscriptions are accepted only for the complete volume.
Orders should be sent with payment to Royal Society of
Medicine Services Limited, Publications Subscription
Department, 'I Wimpole Street, London W1M 8AE, UK
(Tel: 071-408 2119 ext 292; Fax: 071-355 3198).
SOME RECENT PAPERS
-9
Editorial Reviews
Zidovudine in asymptomatic HIV infection: knowledge and uncertainty.
A JPinching (UKJ
Pelvic inflammatory disease: current approaches and ideas.
JHare (UKJ
The investigation of patients with HIV infection. CA Bowman,
CJNLacey (L/KJ
Condylomata acuminata in children. APOranje, FBde waard-van
derSpek, VD Vuzevski fIA B Bi/o (Netherlands)
Neurological manifestations of HIV infection. DRowen, CA Carne (U/4
Azithromycin in sexually transmitted diseases - an overview.
MA Waugh (U/q
Human papillomaviruses and genital neoplasia: the changing scene.
JD Orie/ (ZIKJ
HIV and its relationship to women. CSBradbeer(Ulq
Sexual behaviour, AIDS and poverty in sub-Saharan Africa. A Prua/,
S Chacko, DKoch-weser (N/gei & USA)
Tuberculosis in HIV infection. PJHomer, FMMoss (ZA2
Clinical applications of the polymerase chain reaction. PA Ka'chin (Z//q
Acquired immunodeficiency syndrome and the Epstein-Barr virus.
fyKWLau (ZA2
Original Articles
Evidence of HTLV-I infection in Singapore prostitutes. EHSing,
TTh/rumoodhy, ALevin, SA/exander, /Sng, WB/atMei(Singapore,
UK& USA)
HIV-1 infection in HIV-1 enzyme-linked immunoassay seronegative
patients in Kinshasa, Zaire. ACo%bunders, HFrancis, Af-MDuma
eta/. (Zaire)
Anaerobic vaginosis: study of male sexual partners.
J TArumainayagam, Yde Si/va, MShahmanesh (Z)
Screening colposcopy in genitourinary medicine. PMNathan,
TfI Moss (UKJ
Management of intrameatal warts in men. JGMcKenna, AMcMi//an
IUKI
Rape and HIV. EC/aydon, SMurphy, EMOsbome, VKdchen,
J H S m i t/ i, J R W Ha iri s(U/ Q
A 2-year quantitative assessment of Ch/ainydia trachomatis in a
sexually transmitted diseases clinic population by the MicroTrak
direct smear immunofluorescence test. BJThomas, MFOsborn,
PEMunday, H TEvans, D Tay/or-Hobinson (UKJ
Sexually transmitted diseases in lesbians. AEoYvards, flNThin (UKf
Prevalence of bacterial vaginosis and its association with genital
infections, inflammation, and contraceptive methods in women
attending sexually transmitted disease and primary health clinics.
HMoi (Swede17)
Evaluation of the significance of Mycop/asma hominis and Ureap/asma
ureao/cum in female genital tract infection - a retrospective case
study. SCCrawshaw, D/SYocke,-, DL Sugrue, MVHaran (UKJ
K ----------------------------------------------------------
ORDER FORM
0
Please enter my subscription to International Journal of
STD & AIDS, volume 3 (1992) starting with Part 1.
o Institution a Individual
I enclose payment for £/US$ .......................made payable
to Royal Society of Medicine Services Limited. I wish to
pay by MasterCard/AccessNisa/American Express (delete
as appropriate) and my credit card number is:
..................................................... Expiry..date...........................
Name
....................................................................................................
..............
Address
....................................................................................................
..........
.......................... Postcode............................... Co u
ntry.....................................
Signature
................................................................Date................................
...
Please return this form to Royal Society of Medicine Services
Limited, Publications Subscription Department, 1 Wimpole
a Please send me a specimen copy Street, London W1M BAE, United Kingdom.
R
Y
a
2063654636

.
~
International Journal of STD & AIDS 1992; 3: 338-346
ORIGINAL ARTICLE
Detection of human papillomavirus infections
in the male sexual partners of women
attending an STD clinic in Bologna
Silvano Costa MD1, Stina Syrjanen 2, Calogero Vendral, Fuju Chang2,
Gerardo Guidal, Arja Tervahauta2, Marita Hippelainen3 and
Kari Syrjanen2-4
111 Department of Obstetrics and Gynecology, University of Bologna, Italy; 2Department
of Pathology, University of Kuopio; 3Department of Gynecology & Obstetrics, University
of Kuopio; 4Kuopio Cancer Research Centre, University of Kuopio, Finland
Summary: A series of 65 male sexual partners of 65 women attending an STD clinic
in Bologna, Italy for examination and treatment of genital human papillomavirus
(HPV)-infections during 1990-1991, were examined using peniscopy and surgical
biopsy, the latter being analysed by light microscopy, in situ hybridization'(ISH)
and polymerase chain reaction (PCR) for HPV DNA. A detailed medical and sexual
history was recorded from all men. Of the 65 men, 17 (26.2%) gave a history of a
previous STD. The male partners with previous genital condylomata (14, 21.5% of
men) were significantly associated with the detection of HPV DNA in the current
lesions; 21.4% (3 of 14) and 10.2% (5 of 51) in those with and without previously
treated condyloma, respectively. On colposcopy, 63 (96.9%) men presented with
an abnormal pattern, the vast majority (49 of 65, 75.4%) showing an acetowhite
lesion, and only 12 (18.5%) lesions being classified as condyloma acuminatum. HPV
DNA was found, however, in only 4 of 12 (33.3%) condylomas by ISH and PCR,
and in 4 of 49 (8.2%) and 6 of 49 (12.2%) acetowhite lesions by ISH and PCR,
respectively. In a total of 41 (63%) patients, the biopsy was classified as non-HPV
on light microscopy. HPV DNA detection rate was significantly higher in all
morphologically HPV-suggestive lesions, compared with the non-HPV where ISH
was invariably negative. PCR, however, disclosed HPV DNA in 4 of 41 (9.8%) cases.
PIN (I or II) was present in 6 of 65 (9.2%) men. HPV DNA detection rate increased
in parallel with the increasing grade of lesion, both HPV 16-positive cases containing
a PIN lesion. Altogether, HPV DNA was found by ISH in 8 of 65 (12.3%) biopsies,
and PCR amplification increased the detection rate by only two cases. HPV DNA
was never present in men with only a single sexual partner, but increased
significantly when the number of partners was increased, being highest (27.3%, 3
of 11) in those reporting 11-20 partners. HPV detection rate was lowest in those
men whose partner had a flat condyloma, but significantly higher in those who
presented with condyloma acuminatum (40%, 2 of 5), or HPV-CIN I and II lesions.
Of interest was the finding that HPV DNA was never demonstrated in the men
whose partner had only vaginal HPV lesions. Peniscopy is an applicable means of
finding the abnormal patterns remaining undetectable by the naked eye, but because
of its limited resolution, it is not a conclusive diagnostic tool capable of differentiating
HPV- from non-HPV-lesions.
Keywords: Male sexual partners, HPV infection, peniscopy, PIN, light microscopy
INTRODUCTION exophytic condylomas) in the genital tract with
precancer lesions (CIN, VIN, VAIN, PIN, AIN) and
Current data strongly associates human papillo- invasive squamous cell carcinomas1-5. Almost 70
mavirus (HPV) lesions (ie, flat, inverted and different HPV types have been recognized during
the past 10 years6, and a significant risk for the
Correspondence to: Professor Kari Syrjanen, Department of development of an invasive cancer has been
Pathology, University of Kuopio, POB 1627, SF-70211 Kuopio, ascribed to infections of the high risk
HPV typesz-5.
Finland Of special importance is the mode of transmission
V
4

of this virus by sexual contact, thus conferring a
potential risk for the development of genital
precancer (and eventually cancer) lesions to both
sexual partners7-1z.
Before appropriate prevention can be attempted,
it is essential to identify the reservoirs of the
virus2-4.7-z°. During the past few years, several
reports have been published, in which HPV DNA
has been disclosed by different hybridization
techniques and PCR in normal squamous epithelium
of the genital tract in both sexes, suggesting that
these sites of latent HPV infections might act as such
a reservoir13.14.z1-25.
The role of male sexual partners in transmission of
HPV infections is still highly controversial419.26,27This is partly because of our limited
understanding
of the true prevalence of genital HPV infections in
men. Although the prevalence of clinically manifest
infections (detectable by PAP smear) in a non-
selected female population has been established as
2-3%18-20, and the estimated life-time risk at least
one infection by HPV has been calculated to
approach 80%18, no such figures are available for
men28. It has been estimated that the prevalence of
genital HPV lesions in asymptomatic sexually active
men is probably no higher than 10% in the general
population26.27, whereas the rate of infected male
partners of women with overt condyloma or
abnormal PAP smears is suspected to be considerably
higher, figures from 65% to 85% having been
reported7- 34. However, substantially lower figures
(between 10% and 40%) have been found more
recently in the male sexual partners of HPV-infected
women1635-37
To clarify some of these controversies, the present
study was conducted to assess the prevalence
of genital HPV infections in a high risk male
population, i.e., in the current male sexual partners
of women attending an STD clinic in Bologna, and
reporting a high number of female partners as well.
The techniques used included peniscopy, punch
biopsy, in situ hybridization (ISH) and PCR. Despite
the use of these highly sensitive techniques, the
detection rate of HPV infections remained sur-
prisingly low in this series.
MATERIALS AND METHODS
Patients
A series of 65 male sexual partners of 65 women
attending an STD clinic in Bologna for their genital
HPV infections were invited to take part in the
present study. They were examined at the 2nd
Department of Gynecology & Obstetrics, University
of Bologna between February 1990 and January 1991
using peniscopy and surgical biopsy. A personal
record was filled out and the questions included:
socio-economic status, age, age at first intercourse,
duration of sexual intercourse (at least six months
to be included in the study), number of partners in
total and in the last year, number of episodes of
Costa et al. HPV infection in male sexual partners 339
sexual intercourse a week, symptoms, drug or
alcohol addiction, cigarette smoking, immuno-
suppression as well as previous diagnosis and treat-
ment for condyloma and other venereal infections.
Couples using barrier contraceptive methods (con-
dom, diaphragm), were not included in the study.
Peniscopy
Examination of the male genitalia was performed
with the patient in a lithotomy position on a
standard gynaecology table. The external genitalia
were inspected grossly for evidence of visible
lesions, followed by soaking for 5 min in 5% acetic
acid. The urethral meatus and the entire external
surface of the penis, scrotum, and anus were
systematically inspected by a colposcope with a
magnification of x 7-12. Small surface irregularities,
colour differences and changes in vascularization
can be visualized by this magnification. Additional
acetic acid was applied during the examination by
covering the external genitalia with cotton gauze
pads soaked in acetic acid. The distal urethra was
inspected by a paediatric nasal speculum. If anal
condylomata were present, the anal canal was
inspected by a proctoscope. A small surgical biopsy
was obtained from one or two representative lesions
after subepidermal injection of 1% lidocaine without
epinephrine, using a tuberculin syringe and a
26-gauge needle. Topical lidocaine jelly was often
sufficient for taking a biopsy of the urethral lesions.
Cultures were taken from the urethra for chlamydia.
The peniscopic abnormalities were classified into
one of the following categories: (1) exophytic
condyloma acuminata, (2) acetowhite lesion or (3)
papular lesions35.
Histopathology
The biopsies were fixed in 10% neutral formalin,
embedded in paraffin and processed for light
microscopy according to standard procedures. All
biopsies were evaluated on light microscopy by a
single pathologist (KS), who was not aware of the
colposcopical findings at that stage of the study. The
histological criteria used to classify the lesions into
papillary, flat or endoph tic condylomas have been
previously described23.1~20. In addition, papulosis,
pigmented papulosis and Bowenoid papulosis were
recorded using the criteria outlined previously3s,39
Koilocytosis and superficial cell parakeratosis were
the two most reliable signs of HPV. The lesion was
graded HPV-suggestive if acanthosis or hyper-
keratosis were present. In all the above lesions, the
grade of concomitant penile intraepithelial neoplasia
(PIN) was graded as PIN I, II or III, according to
criteria in common use2.
HPV-DNA in situ hybridization (ISH)
In situ DNA hybridization on formalin-fixed,
paraffin-embedded tissues using biotin-labelled

340
International )ournal of STD & AIDS Volume 3 September/October 1992
Table 1. Characteristics of 65 male patients and their current
female sexual partner
Age (mean±sD) 31.6±7.6
Number of sexual partners (mean+_so) 17.5 +_ 23.0
Previously treated for genital HPV 14 (21.5%)
Smoker 26 (40.0%)
Previously treated for STD:
Chlamydia trachomatis
3 (4.6%)
Candida albicans 9 (13.8%)
Neisseria gonorrhoeae 2 (3.1%)
HSV 1 (1.5%)
Trichomonas vaginalis and condyloma 2 (3.1%)
Clinical or colposcopic findings in female
partner:
Flat condyloma
44 (67.7%)
Condyloma acuminatum 5 (7.7%)
HPV-CIN I 5 (7.7%)
HPV-CIN II 1 (1.5%)
HPV-CIN III 4 (6.2%)
Flat condyloma & condyloma acuminatum 2 (3.1%)
HPV-CIN I & flat condyloma 1 (1.5%)
No data 3 (4.6%)
Site of lesions in female partner:
Cervix
29 (44.6%)
Vagina 5(7.7%)
Vulva 17 (26.2%)
Cervix and vulva 11 (16.9%)
No data 3(4.6%)
Table 2. Peniscopic pattern related to detection
whole ~enomic HPV DNA probes was per-
formed 41. Briefly, 4 µm sections were cut from
each biopsy and mounted on microscopic slides pre-
treated with 1% gamma-amino propyl-triethoxy-
silane (Sigma, St. Louis, MO, USA). The specimens
were hybridized in a mixture of 50% formamide,
10% dextran sulfate, 2 x SSC, 0.4 mg/mi salmon
sperm DNA and biotinylated probe 1.0 µg/ml (HPV
6/11, 16, 18, 31/33) for 16 h at high stringency
conditions (Tm-17). Following the hybridization, the
slides were washed with 2 x SSC for 20 min at room
temperature, 0.2 x SSC at 60°C, followed by 2 x SSC
for 5 min at room temperature. Specimens were
incubated with streptavidin-alkaline phosphatase
complex and successively developed with nitroblue
tetrazolium and bromo-chloro-indoxyl phosphate.
Polymerase chain reaction
11LC VJ I.QDCD Vl 1V111L0.111L-11ACU, 1Ja10.1111L-C11LVClAUCIA
biopsies were further analysed by the PCR 42. One
or more 7 µm sections with an average surface area
> 1 cmz were cut from each block. For PCR, 15 µl of
supernatant was used. The primers were the
consensus primers from L1 (MY 11 and MY09)
described by Manos et al.43. A total of 40 cycles of
of HPV DNA by ISH and PCR
Peniscopic pattern No. of cases HPV type present
6/11 16 18
Acetowhite 49 0 2 0
Condyloma acuminatum 12 3 0 0
Papules 1 0 0 0
Acetowhite and condyloma 1 0 0 0
No data 2 0 0 0
Total series 65 3 2 0
31 33 42
Table 3. Lesion site related to detection of HPV DNA by ISH and PCR
Site of lesion No. of cases HPV type present
6/11 16 18 31
Preputium 50 1 1 0 0
Glans 1 0 0 0 0
Shaft 6 2 0 0 0
Preputium and glans 5 0 1 0 0
Preputium and anus 1 0 0 0 0
No data 2 0 0 0 0
Total series 65 3 2 0 0
33 42
HPV DNA in PCR
Negative Positive
43(87.8%) 6(12.2%)
8(66.7%) 4(33.3%)
1(100%) 0
1(100%) 0
2(100%) 0
55(84.6%) 10(15.4%)
HPV DNA in PCR
Negative Positive
44(88.0%) 6(12.0%)
1(100%) 0
3(50.0%) 3(50.0%)
4(80.0%) 1(20.0%)
1(100%) 0
2(100%) 0
55(84.6%) 10(15.4%)
Table 4. Lesion morphology related to detection of HPV DNA by ISH and PCR
Lesion morphology No. of cases HPV type present HPV DNA in PCR
6/11 16 18 31 33 42 Negative Positive
Non-HPV 41 0 0 0 0 0 0 37(90.2%) 4(9.8%)
Papillary condyloma 1 1 0 0 0 0 0 1(100%) 0
Flat condyloma 14 1 1 0 0 0 0 11(78.6%) 3(21.4%)
Pigmented papulosis 8 1 0 0 0 0 3 6(75.0%) 2(25.0%)
Bowenoid papulosis 1 0 1 0 0 0 0 0 1(100%)
Total series 65 3 2 0 0 0 3 55(84.6%) 10(15.4%)
R
0 ~
w

Costa et al. HPV infection in male sexual partners
amplification of HPV target sequences were carried
out in 50 µl of the reaction mixture with the Gene
Ampli Taq kit and the Perkin Elmer-Cetus automatic
thermal cyder (Perkin Elmer-Cetus, Emeryville, CA,
USA). After initial denaturation, each cycle involved
heating at 95°C for 30 s (DNA denaturation),
followed by cooling at 55°C for 30 S (primer-
annealing), and finally heating at 72°C for 1 min
(chain elongation). Ten microlitres of the amplified
product was electrophoresed in a 3% NuSieve
agarose gell, and the DNAs were visualized in the
gel by ethidium bromide staining. The specific
HPV DNA sequences amplified by the PCR were
subsequently confirmed by Southern blot hybridi-
zation and dot blot hybridization with 32P-labelled
specific HPV probes as described earlier44.
RESULTS
The characteristics and clinical data of the 65 male
patients and their current female sexual partners are
given in Table 1. The age of the 65 males examined
ranged from 20 to 59 years (median 30 years).
Altogether 17 (25.4%) gave a history of a previous
STD. Prior to enrolment in the study, 14 men had
received treatment for genital condylomata. Previous
genital condylomata were significantly associated
with the current detection of HPV DNA; 3 of 14
(21.4%) and 5 of 49 (10.2°!0) in those with and without
previous HPV, respectively. Socioeconomic status,
age, age at first intercourse, duration of sexual
intercourse (at least 6 months to be included in the
study), number of episodes of sexual intercourse a
week, symptoms, drug or alcohol addiction, cigarette
smoking, or immunosuppression did not correlate
the detection rate of HPV DNA.
On colposcopy, 63 (96.9%) men presented with
an abnormal pattern, in 12 (18.5%) the lesion being
classified as condyloma acuminatum (Table 2). The
341
vast majority (49, 75.4%) showed an acetowhite
lesion in the genital tract. HPV DNA was found in
only 4 of 12 (33.3%) condylomas by ISH and PCR,
and in 4 of 49 (8.2%) and 6 of 49 (12.2%) acetowhite
lesions by ISH and PCR, respectively.
The localization of the peniscopic lesions as well
as the detection of HPV DNA are summarized in
Table 3. Most lesions (76.9%) were found on the
preputium, followed by the penile shaft (6 cases).
Involvement of multiple sites was seen in another
6 cases. The highest detection rate of HPV DNA was
encountered in the shaft lesions, where PCR was
positive in 3 of 6 (50%) cases.
The histological findings of the biopsies are shown
in Table 4. In a total of 41 (63%) patients, the biopsy
was classified as non-HPV on light microscopy. A
characteristic flat and exophytic condyloma was
disclosed in 14 (21.5%) cases and 1(1.5°l0)
case, respectively. HPV DNA detection rate
was significantly higher in all morphologically
HPV-suggestive lesions, compared with the non-
HPV, where ISH was invariably negative. PCR,
however, disclosed HPV DNA in 9.8% of these
cases.
PIN was present in 6 (9.2%) men, being graded
as PIN I or II. HPV DNA detection rates increased
in parallel with the increasing grade of lesion (Table
5). Both HPV 16-positive cases contained a PIN
lesion. Altogether, HPV DNA was found by ISH in
12.3% (35.7%) of the biopsies. PCR amplification
increased the detection of HPV DNA by only two
cases.
Table 6 summarizes the relationship between the
number of sexual partners and the detection of HPV
DNA in the men studied. HPV DNA was never
present in men with only a single sexual partner,
but increased significantly when the number of
partners was increased, being highest (27.3%) in
those reporting 11-20 partners.
Table 5. Grade of lesions related to detection of HPV DNA by ISH and PCR
Lesion grade No. of cases HPV'type present
6/11 16 18 31 33
Non-HPV 41 0 0 0 0 0
HPV-NPIN 18 2 0 0 0 0
HPV-PIN 1 5 1 1 0 0 0
HPV-PIN 11 1 0 1 0 0 0
Total series 65 3 2 0 0 0
HPV DNA in PCR
42 Negative Positive
0 37(90.2%) 4(9.8%)
2 15(83.3%) 3(16.7%)
1 3(60.0%) 2(40.0%)
0 0 1(100%)
3 55(84.6%) 10(15.4%)
Table 6. Number of sexual partners related to detection of HPV DNA by ISH and PCR
Number of partners No. of cases HPV type present HPV DNA in PCR
6/11 16 18 31 33 42 Negative Positive
1 6 0 0 0 0 0 0 6(100%) 0
2-5 14 1 0 0 0 0 0 11(78.6%) 3(21.4%)
6-10 16 0 0 0 0 0 1 15(93.8%) 1(6.3%)
11-20 11 0 1 0 0 0 1 8(72.7%) 3(27.3%)
>20 16 2 1 0 0 0 1 13(81.3%) 3(18.8%)
No data 2 0 0 0 0 0 0 2(100%) 0
Total series 65 3 2 0 0 0 3 55(84.6%) 10(15.4%)

~
342 International Journal of STD & AIDS Volume 3 September/October 1992 ~
Table 7. Partner lesions related to detection of HPV DNA by ISH and PCR
Male lesions
Type of lesion No. of cases HPV type present HPV DNA in PCR
in female partner
6/11
16
18
31
33
42
Negative
Positive
Flat condyloma 44 0 0 0 0 0 3 41(93.2%) 3(6.8%)
Condyloma acuminatum 5 2 0 0 0 0 0 3(60.0%) 2(40.0%)
HPV-CIN I 5 1 0 0 0 0 0 3(60.0%) 2(40.0%)
HPV-CIN II 1 0 1 0 0 0 0 0 1(100%)
HPV-CIN III 4 0 0 0 0 0 0 4(100%) 0
Flat condyloma & CA 2 0 1 0 0 0 0 0 2(100%)
HPV-CIN I & Flat 1 0 0 0 0 0 0 1(100%) 0
No data 3 0 0 0 0 0 0 3(100%) 0
Total series 65 3 2 0 0 0 3 55(84.6%) 10(15.4%)
Table 8. Partner lesion site related to detection of HPV DNA by ISH and PCR
Male lesions
Site of lesion No. of cases HPV type present HPV DNA in PCR
in female partner
6/11
16
18
31
33
42
Negative
Positive
Cervix 29 1 1 0 0 0 1 23(79.3%) 6(20.7%)
Vagina 5 0 0 0 0 0 0 5(100%) 0
Vulva 17 2 0 0 0 0 1 15(88.2%) 2(11.8%)
Cervix and vulva 11 0 1 0 0 0 1 9(81.8%) 2(18.2%)
No data 3 0 0 0 0 0 0 3(100%) 0
Total series 65 3 2 0 0 0 3 55(84.6%) 10(15.4%)
Table 7 depicts the female lesions as related to
HPV DNA detection in their male partners. HPV
detection rate was lowest in those males whose
partner had flat condyloma, but significantly higher
in those who presented with condyloma acuminatum
(40%), or HPV CIN I and II lesions (40% and 100%,
respectively).
The site of the female lesion as related to HPV
detection in the male is shown in Table 8. There are
no significant differences between the cervical and
vulvar (or those combined) sites in their association
with male HPV detection rate. Of interest are the
women with only vaginal HPV. lesions in whose
partners HPV DNA was never demonstrated.
DISCUSSION
It seems obvious that the highly divergent pre-
valence of male genital HPV infections reported are
critically dependent on the detection techniques
used, i.e., whether peniscopy, PAP smear, biopsy,
hybridization or PCR, as recently emphasized for
female HPV lesions as we113.4,19,44 The first three
are capable of disclosing only the clinically manifest
lesions, whereas hybridization and especially PCR
can detect the minute quantities of HPV DNA
present in the subclinical and latent infections as
we1134.19,4¢ It seems that the majority of the male
sexual partners of women with condyloma are rarely
aware of their penile lesions, most of them
remaining subclinical or latent45.
It is equally clear that much of the present
controversy in reporting the prevalence of male
HPV infections can be also ascribed to the in-
consistent diagnostic criteria, especially concerning
the subclinical and latent infections, currently
defined as different entities by different wor-
kers3,4,7,i3,14,i8,i9,2i-zs,2s,29,3i-34. Unfortunately, no
consistently reliable diagnostic methods exist for
routine diagnosis of male genital HPV lesions as yet.
During recent years, however, examination of the
male genitalia by colposcopic equipment after
application of 5% acetic acid has been claimed to be
the most reliable method for identification of
subclinical HPV infections293o46 However, no
uniformly accepted colposcopic criteria for the male
lesions have been outlined so far.
The aim of the present study was to establish the
frequency of HPV infections in the male sexual
partners of 65 women attending an STD clinic
for genital HPV infections, and to compare the
sensitivity and specificity of peniscopic examination
with (a) histopathological assessment of the biopsy
and (b) HPV-DNA detection techniques (ISH, and
PCR). While viewing the sexual history of the
present patients, only 17 (25.4%) gave a history of
a previous STD (HPV not included). Prior to
enrolment in the present study, only 14 men
had received treatment for genital condylomata.
Interestingly, this previously treated condyloma
seemed to be strongly associated with the current
detection of HPV DNA in their genital tract; 21.4%
and 10.2%, respectively for those with and those
without previous genital condylomata. This is in full
agreement with the recent findings of Hippelainen
et al.35 who found that previously experienced STD
2063654641

(including HPV) was the most reliable predicting
factor for current HPV infection. This has been
previously suggested by other workers as well45,47The most feasible explanation is to be found in
the
complex natural history of this disease, where
fluctuation between manifest and subclinical or
latent infection during the prolonged disease course
frequently occurs. Thus, in males with previous
genital warts, either reactivation of a regressed
(latent or subclinical) infection or a reinfection from
the sexual partners can be considered as a course of
the currently detectable genital HPV lesionz-4,1$-z°.
Several studies have confirmed the important role
of peniscopic examination in diagnosis of HPV
lesions on the male external genitalia8-3o,4s This
view is substantiated by the present results. On
peniscopy, 63 (96.9%) men presented with an
abnormal pattern, the vast majority (75.4%) showing
an acetowhite lesion in the genital tract. This is in
agreement with the recent reports where acetowhite
lesions were encountered in the vast majority of
male partners of HPV-infected women14,ss34,49-51
In 12 (18.5%) cases, the lesion was classified
as condyloma acuminatum on peniscopy. The
detection rate of HPV DNA was significantly
associated with the peniscopic pattern; 4 of 12
(33.3%) condylomas by ISH and PCR, and 4 of 49
(8.2%) and 6 of 49 (12.2%) acetowhite lesions by ISH
and PCR, respectively. This clearly indicates that the
accuracy of peniscopy is critically dependent on the
morphology of the findings. Difficulties arose
especially in the correct assessment of flat lesions,
because of the variety of factors responsible for
acetowhite staining; nonspecific infections, healing
areas after treatment, etc. The majority of the flat
lesions were invisible before acetic acid. Acetowhite
areas varied in number, size, surface characters, and
time of reaction. In particular, this feature was
frequently found on the prepuce, less frequently on
the glans, and on the penile skin as has been
reported by other authors48. HPV DNA detection
rate was highest in the shaft lesions (50%), ~however,
indicating that colposcopic abnormality in that area
is much more frequently associated with HPV as
compared with those in preputium, where HPV
DNA was found in 12% of the lesions only (Table 3).
This also suggests that the accuracy of peniscopic
diagnosis is dependent on the localization of the
lesion, as recently discussed by Hippelainen et al.35,
being high in the meatus, less so in the glans, and
lowest in the preputium.
The above data clearly indicate that acetowhite
lesions in the preputium frequently develop due to
causes other than HPV. This impression was
confirmed by the histological examination of the
biopsies (Table 4). On light microscopy, the biopsy
was classified as non-HPV in 41 (63%) patients. A
characteristic flat and exophytic condyloma was
disclosed in 14 (21.5%) and 1 (1.5%) cases, res-
pectively. HPV DNA detection rate was significantly
higher in all morphologically HPV-suggestive
lesions, compared with the non-HPV, where ISH
Costa et al. HPV infection in male sexual partners 343
was invariably negative. The latter observation is
fully consistent with the previous experience in the
female genital tract where HPV DNA was never
found in a histologically normal epithelium52.
Similarly, in a recent study where biopsies were
taken from peniscopically normal male genitalia,
1 cm adjacent to the suspected HPV lesion, and HPV
DNA was never found by ISH35. In the present
series, however, PCR disclosed HPV DNA in 9.8%
of such cases. Similarly, Nuovo et a1.16 found HPV
DNA in 20% of normal penile biopsies negative with
ISH. In a recent report of Kataoka et al. 12, HPV
DNA was found in 6% of normal epithelium by
Southern blot, and in 12% by PCR. It is reasonable
that the frequency of HPV infections increases when
DNA techniques are applied23-29,53 With the highly
sensitive DNA techniques (ISH, PCR), minute
amounts of viral DNA can be detected that are
most probably not capable of causing cytopathic
effects in epithelial cells. With these techniques,
subclinical and latent HPV infections could be
detected in the epithelium that appears normal
on gross, colposcopic, cytologic and histologic
examination4-44.
The correlation between colposcopy, histology
and ISH (or PCR) was not particularly good in the
present series. HPV DNA was found in only 33.3%
even of the peniscopically typical condylomas and
much less frequently in acetowhite lesions (12.2%).
The correlation between histology and DNA hybrid-
ization was of the same order, only 8 lesions
containing HPV DNA by ISH (Table 4). The use of
PCR increased the detection rate by two cases only.
Overall, the detection rate of HPV DNA seems to
be significantly lower than that obtained in cervical
or vaginal biopsies of clinically manifest HPV
lesions54. In fact, the DNA detection rate was of
similar magnitude to that of subclinical and latent
HPV infections in the female genital tract". As
discussed above, HPV DNA detection rates sig-
nificantly higher than those of the present series
have been previously reported7-29-34. On the other
hand, there are well conducted studies where the
prevalence of male genital HPV lesions seem to be
close to that of the present series11,16,3637The
reasons for our relatively low figures might be either
one or all of the following: (1) the penile lesions
contained HPV types other than those included in
the present test panel; (2) biopsies were not from
the most representative areas of HPV lesions; or (3)
the lesions disclosed are not related to HPV
infection. The previously suggested explanation that
DNA content was below the detection limits of ISH
can be excluded in this case, because of the fact that
PCR increased the ISH detection rate only by two
cases. Altogether, these data fully confirm the
discrepancy still existing in the prevalence figures
of male genital HPV lesions, depending on (a) the
patient population studied, and (b) the technique
used. Concerning the latter, also the importance of
standardization of the PCR techniques (e.g. primer
selection) should be emphasized.

344 International Journal of STD & AIDS Volume 3 September/October 1992
In the present series, six PIN lesions were
discovered, four of which contained HPV DNA
either by ISH or PCR (Table 5). Three of these
positive cases represented the high risk HPV types,
i.e. HPV 16 or 42. In general, HPV DNA detection
rate increased in parallel with the increasing grade
of lesion, which is also in agreement with a number
of recent studies7. A single case of Bowenoid
papulosis contained HPV 16 DNA, which is
consistent with the previous concepts on this
particular entity3$39. These results indicate that
among the male genital lesions, PIN lesions are
quite rare occurrences which supports the data from
other recent series35.
As related to the number of sexual partners, the
detection of HPV DNA increased significantly when
the number of partners was increased, being highest
(27.3%) in those reporting 11-20 female partners.
Noteworthy was the observation that HPV DNA
was never found in those males with only a single
sexual partner (Table 6). Even the existence of 2-5
partners increased the detection rate to 21.4%,
whereas the history of more than 20 partners did not
further increase these figures. These observations
support the concept of the important role of direct
sexual contact as a mode of transmission of male
genital HPV infections, as emphasized before7-12. It
may well be that there are significant differences in
infectivity between the clinical, subclinical and latent
HPV infections, as well as between HPV lesions
with different morphology, and between those at
different localization. The latter concept is also
supported by the observations in the present study,
where HPV detection rate was lowest in the
males whose partner had a flat condyloma, but
significantly higher in those who presented with
condyloma acuminatum (40%), or HPV CIN I and
II lesions (40% and 100%, respectively). Similarly,
of interest was the finding that HPV DNA was never
demonstrated in the males whose partners had
only vaginal HPV lesions, although no significant
differences were observed between the cervical and
vulvar (or those combined) sites in this respect.
Barrasso et al.7 suggested that the acetic acid test
can be used as a screening method by any physician
with help of a hand lens, because most of the
macular and papular lesions that become white
upon application of acetic acid could be detected by
a careful clinical examination. In our practice,
peniscopic examination was carried out entirely
analogous to the technique of vulvar and perianal
colposcopy in women. According to the present
results, acetic acid test and peniscopy were not
specific enough to discriminate between HPV-
lesions and other non-HPV-related epithelial
changes. It seems justified to conclude that peniscopic
examination of the male genitalia seems to be
helpful in the diagnosis of HPV infection, but it
should not be used as the only conclusive diagnostic
tool. Peniscopic overdiagnosis is the rule when
biopsies are evaluated on light microscopy or by
HPV DNA detection with ISH or PCR. To summarize,
more data are needed to elucidate fully the
significance of the male sexual partners in patho-
genesis of the squamous cell tumours of the female
genital tract.
Acknowledgements: This study was supported by a
research grant from the Finnish Cancer Society,
a research contract (No. 1041051) from the Medical
Research Council of the Academy of Finland, a joint
research grant from Fabriques de Tabac Reunies
S.A., and British <American Tobacco Company Ltd,
and CNR Grant No. 8800783, Progetto finalizzato
oncologia e finanziamento Regione Emilia-Romana
(Progetto di ricerca Oncologia). The skilful technical
assistance of Ms Paula Lipponen, Mrs Kaarina
Hoffren, Ms Helena Kemilainen, and Mrs Eija
Sedergren-Varis is gratefully acknowledged. The
authors want to extend their special thanks to
Professor Dr Harald zur Hausen, DKFZ, Heidelberg,
West Germany, and Professor Gerard Orth, Pasteur
Institute, Paris, France, for providing the HPV DNA
probes.
References
1 Gissmann L. Papillomaviruses and their association with
cancer in animals and in man. Cancer Surv 1984;3:161-78
2 Syrjanen K, Gissmann L, Koss LG, eds. Papillotnaviruses and
human disease. Heidelberg: Springer Verlag, 1987
3 Syrjanen KJ. Epidemiology of human papillomavirus (HPV)
infections and their associations with genital squamous cell
cancer. APMIS 1989;97:957-70
4 Syrjanen KJ. Genital human papillomavirus (HPV) infections
and their associations with squamous cell cancer: Reapprisal
of the morphologic, epidemiologic and DNA data. Progr Surg
Pathol 1992;xii:217-40
5 zur Hausen H. Papillomavirus in anogenital cancer: the
dilemma of epidemiologic approaches. I Natl Cancer Inst
1989;81:1681-2
6 de Villiers EM. Heterogeneity of the human papillomavirus
group. I Virol 1989;63:4898-903
7 8arrasso R, de Brux J, Croissant 0, Orth G. High prevalence
of papillomavirus-associated penile intraepithelial neoplasia
in sexual partners of women with cervical intraepithelial
neoplasia. N Engl J Med 1987;317:916-23
8 Campion MJ, Singer A, Clarkson PK. Increased risk of
cervical neoplasia in consorts of men with penile condylomata
acuminata. Lancet 1985;i:943-6 ,
9 Brinton LA, Reeves WC, Brenes MM, et al. The male factor
in the etiology of cervical cancer among sexually monogamous
women. Int I Cancer 1989;44:199-203
10 Caroti S, Siliotti F, Caroti A. Male genital condylomatosis
in partners of females affected with HPV infections. Clinical
statistical contribution. Clin Exp Obstet Gynecol 1990;17:181-3
11 Karonel R, Stefanon B, Pilotti S, Bandieramonte G, Rilke F,
de Paolo G. Genital human papilloma virus infection in
males. A clinico-pathologic study. Tumori 1991;77:76-82
12 Kataoka A, Claesson U, Hansson BG, Eriksson M, Lindh E.
Human papillomavirus infection of the male diagnosed by
Southern-blot hybridization and polymerase chain reaction:
comparison between urethra samples and penile biopsy
samples. J Med Virol 1991;33:159-64
13 McNicol PJ, Dodd JG. Detection of human papillomavirus
DNA in prostate gland tissue by using the polymerase chain
reaction amplification assay. J Clin Microbiol 1990;28:409-12
I I
t
i
2063654643

.
14 Massone L, Anonide A, Pestarino A, Solari G, Priano L, Isola
V. Lesioni subcliniche HPV-indotte dei genitali maschili. Uso
del colposcopio. Git Derm Vener 1990;125:183-6
15 Melchers WJG, Schift R, Stolz E, Lindeman J, Quint WGV.
Human papillomavirus detection in urine samples from male
patients by the polymerase chain reaction. J Clin Microbiol
1989;27:1711-14
16 Nuovo GJ, Hochman HA, Eliezri YD, Lastarria D, Comite
SL, Silvers DN. Detection of human papillomavirus DNA
in penile lesions histologically negative for condylomata.
Q nalysis by in situ hybridization and the polymerase chain
reaction. Ain J Surg Pathol 1990;14:829-36
17 Omar R, Choudhury M, Fischer J, Ezpeleta C. A "PAP" test
for men? Male urethral smears as screening tool for detecting
subclinical human papillomavirus infection. Urology 1991;
37:110-15
18 Syrjanen K, Hakama M, Saarikoski S, et al. Prevalence,
incidence and estimated life-time risk of cervical human
papillomavirus (HPV) infections in nonselected Finnish
female population. Sex Transm Dis 1990;17:15-19
19 Syrjanen KJ. Natural history of genital HPV infections.
Papillomavirus Rep 1990;1:1-5
20 Syrjanen K, Yliskoski M, Kataja V, et al. Prevalence of genital
human papillomavirus (HPV) infections in a mass-screened
Finnish female population aged 20-65 years. Int J STD AIDS
1990;1:410-15
21 Meanwell CA, Blackledge G, Cox MF, Maitland NJ. HPV
16 DNA in normal and malignant cervical epithelium:
implications for the aetiology and behaviour of cervical
neoplasia Lancet 1987;i:703-7
22 Fife KH, Rogers RE, Zwickl BW. Symptomatic and
asymptomatic cervical infections with human papillomavirus
during pregnancy. J Infect Dis 1987;156:904-11
23 Macnab JCM, Walkinshaw SA, Cordiner JW, Clements JB.
Human papillomavirus in clinically and histologically normal
tissue of patients with genital cancer. N Engl J Med
1986;315:1052-8
24 Wickenden C, Malcolm ADB, Steele A, Coleman DV. Screening
for wart virus infection in normal and abnormal cervices by
DNA hybridization of cervical scrapes. Lancet 1985;i:65-7
25 Katelaris PM, Cossart YE, Rose BR, et al. Human papilloma-
virus: the untreated male reservoir. J Urol 1988;140:300-5
26 Schneider A, Sawada E, Gissmann L, Shah K. Human
papilIomaviruses in women with a history of abnormal
papanicolaou smears and in their male partners. Obstet
G ynecol 1987; 69:554-62
27 Schneider A, Kirchmayr R, de Villiers E-M, Gissmann L.
Subclinical human papillomavirus infections in male sexual
partners of female carriers. J Urol 1988;140:1431-4
28 Schneider A. Latent and subclinical genital HPV infections.
Papillomavirus Rep 1990;1:2-5
29 Levine RV, Crum CP, Herman E, et al. Cervical papilloma-
virus infection and intraepithelial neoplasia: a study of male
sexual partners. Obstet Gynecol 1984; 64:16
30 Krebs H-B, Schneider V. Human papillomavirus-associated
lesions of the penis: colposcopy, cytology, and histology. Clin
Obst Gynecol 1987;70:299-304
31 Krebs H-B. Genital HPV infections in men. Clin Obstet Gynecol
1989;32:180-9
32 Rosenberg SK, Greenberg MG, Reid R. Sexually transmitted
papilloma-virus infection in men. Obstet Gynecol Clin North
Am 1987;14:495-507
33 Sand PK, Bowen LW, Blischke SO, Ostergard DR. Evaluation
of male consorts of women with genital human papilloma
virus infection. Obstet Gynecol 1986;68:679-81
34 Wikstrom A, Lidbrink P, Johansson B, von Krogh G. Penile
human papillomavirus carriage among men attending
Swedish STD clinics. Int J STD AIDS 1991;2:105-9
Costa et al. HPV infection in male sexual partners 345
35 Hippelainen M, Yliskoski M, Saarikoski S, Syrjanen S,
Syrjanen K. Colposcopic analysis of genital human papilloma-
virus (HPV) lesions of the male sexual partners. Genitourin
Med 1991;67:291-6
36 Giacomini G, Bianchi G, Moretti D. Detection of sexually
transmitted diseases by urethral cytology, the ignored male
counterpart of cervical cytology. Int Acad Cytol 1988;19:
11-15
37 Nahhas WA, Marshall ML, Ponziani J, Jagielo JA. Evaluation
of urinary cytology of male sexual partners of women with
cervical intraepithelial neoplasia and human papilloma virus
infection. Gynecol Oncol 1986;24:279-85
38 Gross G, Ikenberg H, Gissmann L, Hagedorn M. Papilloma-
virus infection of the anogenital region: correlation between
histology, clinical picture, and virus type. Proposal of a new
nomenclature. J Invest Dermatol 1985;85:147-52
39 Gross G, Hagedorn M, Ikenberg H, et al. Bowenoid
papulosis. Presence of human papillomavirus (HPV)
structural antigens and of HPV 16-related DNA sequences.
Arch Dermatol 1985;121:858-63
40 Syrjanen S, Syrjanen K. An improved in situ hybridization
protocol for detection of human papillomavirus (HPV) DNA
sequences in paraffin-embedded biopsies. J Virol Methods
1986;14:293
41 Syrjanen S, Partanen P, Mantyjarvi R, Syrjanen K. Sensitivity
of in situ hybridization techniques using biotin and 35S-
labeled human papillomavirus (HPV) DNA probes. J Virol
Methods 1988;19:225-38
42 Kallio P, Syrjanen S, Tervahauta A, Syrjanen K. A simple
isolation of DNA from formalin-fixed, paraffin-embedded
samples for PCR. I Virol Methods 1991;35:39-47
43 Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR,
Wolinsky SM. The use of polymerase chain reaction
amplification for the detection of genital human papilloma-
viruses. Cancer Cells 1989;7:209-14
44 Syrjanen S, Saastamoinen J, Chang F, Ji Hx, Syrjanen K.
Colposcopy, punch biopsy, in situ hybridization and
polymerase chain reaction in search for genital human
papillomavirus (HPV) infections in women with normal PAP
smears. J Med Virol 1990;31:259-66
45 Stone K. Epidemiologic aspects of genital HPV infection. Clin
Obstet Gynecol 1989;32:112-16
46 Sedlacek TV, Cunnane M, Carpiniello V. Colposcopy in the
diagnosis of penile condyloma. Arn I Obstet Gynecol 1986;154:
494-6
47 Bistoletti P, Lindbrink P. Sexually transmitted diseases
including genital papillomavirus infection in the male sexual
partners of women treated for cervical intraepithelial
neoplasia III by conization. Br J Obstet Gynecol 1988;95:
611-13
48 Kennedy L, Buntine DW, O'Connor D, Frazer IH. Human
papillomavirus-a study of male sexual partners. Med I Aust
1988;149:309-11
49 Aynaud 0, Arvis G, lonesco M. Peniscopie de depistage de
lesions a papillomavirus chez 400 patients. Contraception Fertil
Sex 1991;19:145-8
50 Boon ME, Schneider A, Hogewoning CJA, van der Kwast
TH, Bolhuis P, Kok LP. Penile studies and heterosexual
partners. Cancer 1988;61:1652-9
51 Hudson S, Dehaeck K, Soeters RP, Bloch B. Penile human
papillomavirus infection in consorts of women with genital
human papillomavirus infection. S Afr Med J 1988;74:
511-12
52 Syrjanen KJ, Syrjanen SM. Concept on the existence
of human papillomavirus (HPV) DNA in histologic-
ally normal squamous epithelium of the genital tract
should be re-evaluated. Acta Obstet Gynecol Scand 1989;68:
613-17
